2-Methoxyestradiol

2-Methoxyestradiol
2-Methoxyestradiol
Systematic (IUPAC) name
(8R,9S,13S,14S,17S)-2-methoxy-
13-methyl-6,7,8,9,11,12,14,15,16,17-
decahydrocyclopenta[a]phenanthrene-3,17-diol
Clinical data
Pregnancy cat.  ?
Legal status  ?
Identifiers
CAS number 362-07-2 N
ATC code  ?
PubChem CID 66414
ChemSpider 59788 YesY
UNII 6I2QW73SR5 YesY
ChEBI CHEBI:28955 YesY
ChEMBL CHEMBL299613 YesY
Chemical data
Formula C19H26O3 
Mol. mass 302.408 g/mol
SMILES eMolecules & PubChem
 N(what is this?)  (verify)

2-Methoxyestradiol (2ME2) is a drug that prevents the formation of new blood vessels that tumors need in order to grow (angiogenesis). It is derived from estrogen, although it binds poorly to known estrogen receptors, and belongs to the family of drugs called angiogenesis inhibitors. It has undergone Phase 1 clinical trials against breast cancers. Preclinical models also suggest that 2ME2 could also be effective against inflammatory diseases such as rheumatoid arthritis. The CAS name for 2ME2 is (17 beta)-2-methoxyestra-1,3,5(10)-triene-3,17-diol. It also acts as a vasodilator. Several studies have been conducted showing 2ME2 is a microtubule-inhibitor and effective against prostate cancer in rodents.

External links